Bharat Biotech ramps up Covaxin production to 70 crore doses per year | Editorji
  1. home
  2. > national
  3. > Bharat Biotech ramps up Covaxin production to 70 crore doses per year
prev iconnext button of playermute button of playermaximize icon
mute icontap to unmute
video play icon
00:00/00:00
prev iconplay paus iconnext iconmute iconmaximize icon
close_white icon

Bharat Biotech ramps up Covaxin production to 70 crore doses per year

Apr 20, 2021 17:53 IST | By Editorji News Desk

Biotechnology company Bharat Biotech announced that they will expand the production of their Covid-19 vaccine Covaxin to support vaccination campaigns in India and worldwide amid the resurgence of the coronavirus cases.

The capacity expansion has been implemented across multiple facilities in Hyderabad and Bangalore, to reach over 70 crore doses per year.

The move came ahead of opening the vaccination drive to all citizens over 18 years of age.

Also Read | 'Bad planning': Delhi HC pulls up Centre over vaccine wastage

National